Fortunately18 Nov 2024 11:06
Following IRB clearance, a Site Initiation Visit (SIV) is expected to take place in the third week of November, marking the official launch of the Phase I clinical trial. -> THIS comes from MD Anderson, NOT Hemogenyx so the date should be dependable and less likely to change. Whilst pwil is correct, everyone on this board is fairly certain its happening and already bought in, at this point for any serious movement we dont matter.
What matters is Going clinical is THE BIGGEST change in the history of Hemogenyx, launch of trial is a HUGE transition, the PR and publicity that comes with it will attract many faces who have never seen nor heard of Hemogenyx before. THEY are who matter and they will decide what its worth based on the market and not the traders/LTH already here. The market decides, and the market will decide, and the tiny pool of fish here who think they can influence the price when this actually goes clinical are in for a big awakening!
Volume is all, something we have rarely seen here, when it happens the traders and shorters disappear, they dont even try. THAT is what happens when you go clinical and suddenly people are talking about Hemo. Its not about results at this point, people dont buy results, they buy the rumor, they buy the potential and they sell on news, good or bad. Start of trials means someone soon gets injected and within weeks we know if this gets a clinical hold or is allowed to continue, either way, the waiting is over. There is no guarantee it will work, but if it does??????